Baker Bros. Advisors as of June 30, 2022
Portfolio Holdings for Baker Bros. Advisors
Baker Bros. Advisors holds 117 positions in its portfolio as reported in the June 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Seagen | 47.1 | $8.3B | 47M | 176.94 | |
Incyte Corporation (INCY) | 15.6 | $2.7B | 36M | 75.97 | |
BeiGene Sponsored Adr (BGNE) | 10.7 | $1.9B | 12M | 161.85 | |
BioMarin Pharmaceutical (BMRN) | 3.6 | $632M | 7.6M | 82.87 | |
ACADIA Pharmaceuticals (ACAD) | 3.4 | $591M | 42M | 14.09 | |
Ascendis Pharma A/S Sponsored Adr (ASND) | 2.6 | $451M | 4.9M | 92.96 | |
argenx SE Sponsored Adr (ARGX) | 2.4 | $424M | 1.1M | 378.88 | |
BioCryst Pharmaceuticals (BCRX) | 0.8 | $135M | 13M | 10.58 | |
Kodiak Sciences (KOD) | 0.8 | $132M | 17M | 7.64 | |
Global Blood Therapeutics In | 0.7 | $119M | 3.7M | 31.95 | |
Abcellera Biologics (ABCL) | 0.6 | $111M | 11M | 10.65 | |
Madrigal Pharmaceuticals (MDGL) | 0.6 | $107M | 1.5M | 71.58 | |
Mirati Therapeutics | 0.5 | $95M | 1.4M | 67.13 | |
Immunocore Holdings Ads (IMCR) | 0.5 | $94M | 2.5M | 37.31 | |
Horizon Therapeutics Public SHS | 0.5 | $92M | 1.1M | 79.76 | |
Cerus Corporation (CERS) | 0.5 | $85M | 16M | 5.29 | |
Travere Therapeutics (TVTX) | 0.5 | $80M | 3.3M | 24.23 | |
Replimune Group (REPL) | 0.4 | $63M | 3.6M | 17.48 | |
Entrada Therapeutics (TRDA) | 0.3 | $59M | 4.9M | 12.18 | |
Igm Biosciences (IGMS) | 0.3 | $57M | 3.2M | 18.03 | |
Kymera Therapeutics (KYMR) | 0.3 | $57M | 2.9M | 19.69 | |
Krystal Biotech (KRYS) | 0.3 | $53M | 808k | 65.66 | |
Prelude Therapeutics (PRLD) | 0.3 | $53M | 10M | 5.22 | |
Nurix Therapeutics (NRIX) | 0.3 | $49M | 3.9M | 12.67 | |
Legend Biotech Corporation Sponsored Ads (LEGN) | 0.3 | $47M | 857k | 55.00 | |
Alkermes SHS (ALKS) | 0.3 | $45M | 1.5M | 29.79 | |
Chemocentryx | 0.3 | $44M | 1.8M | 24.78 | |
Chinook Therapeutics | 0.3 | $44M | 2.5M | 17.49 | |
Insmed Incorporated Com Par $.01 (INSM) | 0.2 | $43M | 2.2M | 19.72 | |
Immatics SHS (IMTX) | 0.2 | $39M | 4.4M | 8.71 | |
DBV Technologies Sponsored Adr | 0.2 | $37M | 15M | 2.55 | |
Sarepta Therapeutics DBCV 1.5% 11/15/2024 (Principal) | 0.2 | $37M | 29M | 1.25 | |
Insmed Incorporated Note 0.75% 6/1/2028 (Principal) | 0.2 | $33M | 40M | 0.83 | |
Aerovate Therapeutics (AVTE) | 0.2 | $32M | 2.1M | 15.63 | |
Amarin Corporation Sponsored Adr (AMRN) | 0.2 | $32M | 21M | 1.49 | |
Verastem | 0.2 | $31M | 27M | 1.16 | |
Ultragenyx Pharmaceutical (RARE) | 0.2 | $28M | 471k | 59.66 | |
2seventy bio Common Stock (TSVT) | 0.2 | $27M | 2.1M | 13.20 | |
Kiniksa Pharmaceuticals Com Cl A | 0.2 | $27M | 2.8M | 9.69 | |
Biomea Fusion (BMEA) | 0.1 | $25M | 2.1M | 11.98 | |
Altimmune (ALT) | 0.1 | $24M | 2.1M | 11.70 | |
Invitae (NVTAQ) | 0.1 | $24M | 9.9M | 2.44 | |
Pacific Biosciences of California (PACB) | 0.1 | $24M | 5.4M | 4.42 | |
Xenon Pharmaceuticals (XENE) | 0.1 | $23M | 752k | 30.42 | |
Heron Therapeutics (HRTX) | 0.1 | $23M | 8.1M | 2.79 | |
Merus N V (MRUS) | 0.1 | $23M | 995k | 22.64 | |
Verve Therapeutics (VERV) | 0.1 | $22M | 1.4M | 15.28 | |
Design Therapeutics (DSGN) | 0.1 | $20M | 1.4M | 14.00 | |
Affimed Therapeutics B V | 0.1 | $18M | 6.6M | 2.77 | |
Instil Bio | 0.1 | $18M | 3.9M | 4.62 | |
Otonomy | 0.1 | $18M | 8.4M | 2.08 | |
Denali Therapeutics (DNLI) | 0.1 | $17M | 589k | 29.43 | |
Rhythm Pharmaceuticals (RYTM) | 0.1 | $17M | 4.1M | 4.15 | |
Opthea Sponsored Ads (OPT) | 0.1 | $17M | 2.7M | 6.30 | |
Adaptimmune Therapeutics Sponsored Adr (ADAP) | 0.1 | $17M | 9.8M | 1.70 | |
Crinetics Pharmaceuticals In (CRNX) | 0.1 | $15M | 828k | 18.65 | |
Tricida | 0.1 | $15M | 1.5M | 9.68 | |
Forma Therapeutics Holdings SHS | 0.1 | $14M | 2.0M | 6.89 | |
Fulgent Genetics (FLGT) | 0.1 | $11M | 201k | 54.53 | |
Bluebird Bio (BLUE) | 0.1 | $10M | 2.5M | 4.14 | |
Relmada Therapeutics (RLMD) | 0.1 | $9.4M | 495k | 18.99 | |
Dice Therapeutics | 0.1 | $9.1M | 588k | 15.52 | |
Zymeworks | 0.1 | $9.1M | 1.7M | 5.30 | |
Karuna Therapeutics Ord | 0.1 | $8.9M | 70k | 126.50 | |
Tscan Therapeutics (TCRX) | 0.0 | $8.8M | 2.8M | 3.14 | |
Anaptysbio Inc Common (ANAB) | 0.0 | $8.7M | 427k | 20.30 | |
Fibrogen (FGEN) | 0.0 | $8.6M | 816k | 10.56 | |
Invitae Corporation Note 2.0% 9/1/2024 (Principal) | 0.0 | $8.1M | 10M | 0.79 | |
Cyteir Therapeutics | 0.0 | $7.9M | 2.6M | 2.99 | |
Surrozen | 0.0 | $7.5M | 2.5M | 3.00 | |
Reata Pharmaceuticals Cl A | 0.0 | $6.8M | 224k | 30.39 | |
Achilles Therapeutics Sponsored Ads (ACHL) | 0.0 | $6.5M | 2.6M | 2.52 | |
Cymabay Therapeutics | 0.0 | $6.4M | 2.2M | 2.95 | |
Atreca Cl A Com (BCEL) | 0.0 | $6.3M | 3.5M | 1.79 | |
Talis Biomedical Corp | 0.0 | $6.2M | 7.6M | 0.81 | |
Harmony Biosciences Hldgs In (HRMY) | 0.0 | $6.0M | 124k | 48.77 | |
Atara Biotherapeutics | 0.0 | $5.8M | 744k | 7.79 | |
Vor Biopharma (VOR) | 0.0 | $5.7M | 1.1M | 4.97 | |
Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.0 | $5.5M | 1.1M | 4.87 | |
Nkarta (NKTX) | 0.0 | $4.9M | 400k | 12.32 | |
Vera Therapeutics Cl A (VERA) | 0.0 | $4.5M | 333k | 13.61 | |
Revolution Medicines (RVMD) | 0.0 | $4.3M | 222k | 19.49 | |
Edgewise Therapeutics (EWTX) | 0.0 | $4.0M | 500k | 7.96 | |
Neoleukin Therapeutics | 0.0 | $3.9M | 3.8M | 1.03 | |
Hookipa Pharma Inc equity | 0.0 | $3.9M | 2.4M | 1.63 | |
Natera (NTRA) | 0.0 | $3.5M | 100k | 35.44 | |
Tango Therapeutics (TNGX) | 0.0 | $3.4M | 750k | 4.53 | |
Athira Pharma (ATHA) | 0.0 | $3.2M | 1.0M | 3.05 | |
Iteos Therapeutics (ITOS) | 0.0 | $3.1M | 150k | 20.60 | |
Evofem Biosciences | 0.0 | $2.9M | 2.6M | 1.13 | |
Macrogenics (MGNX) | 0.0 | $2.6M | 893k | 2.95 | |
Aligos Therapeutics (ALGS) | 0.0 | $2.5M | 2.1M | 1.21 | |
Alector (ALEC) | 0.0 | $2.4M | 239k | 10.16 | |
Bioatla (BCAB) | 0.0 | $2.4M | 825k | 2.85 | |
Allakos (ALLK) | 0.0 | $2.2M | 703k | 3.13 | |
Tcr2 Therapeutics Inc cs | 0.0 | $2.2M | 753k | 2.90 | |
Syndax Pharmaceuticals (SNDX) | 0.0 | $2.1M | 111k | 19.24 | |
Aeglea Biotherapeutics | 0.0 | $1.7M | 3.4M | 0.51 | |
Epizyme | 0.0 | $1.5M | 1.0M | 1.47 | |
Akero Therapeutics (AKRO) | 0.0 | $1.1M | 118k | 9.45 | |
Atyr Pharma (ATYR) | 0.0 | $1.1M | 374k | 2.83 | |
Genetron Holdings Ads | 0.0 | $774k | 455k | 1.70 | |
Ngm Biopharmaceuticals | 0.0 | $709k | 55k | 12.82 | |
Cabaletta Bio (CABA) | 0.0 | $702k | 662k | 1.06 | |
Leap Therapeutics | 0.0 | $644k | 560k | 1.15 | |
Foghorn Therapeutics (FHTX) | 0.0 | $612k | 45k | 13.59 | |
Burning Rock Biotech Sponsored Ads | 0.0 | $609k | 209k | 2.91 | |
Protara Therapeutics Com Stk (TARA) | 0.0 | $585k | 200k | 2.93 | |
Kezar Life Sciences (KZR) | 0.0 | $512k | 62k | 8.27 | |
Inozyme Pharma (INZY) | 0.0 | $510k | 107k | 4.77 | |
Sera Prognostics Class A Com (SERA) | 0.0 | $331k | 202k | 1.64 | |
Vincera Pharma (VINC) | 0.0 | $319k | 241k | 1.32 | |
Bellicum Pharmaceuticals | 0.0 | $296k | 249k | 1.19 | |
Passage Bio (PASG) | 0.0 | $276k | 117k | 2.36 | |
Surrozen W Exp 8/11/2026 (SRZNW) | 0.0 | $159k | 833k | 0.19 | |
Logicbio Therapeutics | 0.0 | $158k | 452k | 0.35 | |
Neximmune | 0.0 | $32k | 20k | 1.60 |